Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Gabriel T. Liberatore; Vernice Jackson-Lewis; Slobodanka Vukosavic; Allen S. Mandir; Miquel Vila; W. Geoffrey McAuliffe; Valina L. Dawson; Ted M. Dawson; Serge Przedborski

doi:10.1038/70978

journal article Dec 01, 1999

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Gabriel T. Liberatore Vernice Jackson-Lewis Slobodanka Vukosavic Allen S. Mandir Miquel Vila

W. Geoffrey McAuliffe Valina L. Dawson

Ted M. Dawson

Serge Przedborski

Nature Medicine Vol. 5 No. 12 pp. 1403-1409 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/70978

Topics

No keywords indexed for this article. Browse by subject →

References

51

[1]

Fahn, S. in Cecil's Textbook of Medicine vol.18 (eds. Wyngaarden, J.B. & Smith, L.H.Jr.) 2143–2147 (Saunders, Philadelphia, 1988).

[2]

Pakkenberg, B., Moller, A., Gundersen, H.J.G., Mouritzen, A. & Pakkenberg, H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiat. 54, 30–33 (1991). 10.1136/jnnp.54.1.30

[3]

Hornykiewicz, O. & Kish, S.J. in Parkinson's Ddisease (eds. Yahr, M. & Bergmann, K.J.) 19– 34 (Raven, New York, 1987).

[4]

Kostic, V., Przedborski, S., Flaster, E. & Sternic, N. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology 41, 202–205 (1991). 10.1212/wnl.41.2_part_1.202

[5]

Langston, J.W. & Irwin, I. MPTP: current concepts and controversies. Clin. Neuropharmacol. 9, 485– 507 (1986). 10.1097/00002826-198612000-00001

[6]

Przedborski, S. & Jackson-Lewis, V. Mechanisms of MPTP toxicity. Mov. Disord. 13, 35– 38 (1998).

[7]

Przedborski, S. & Jackson-Lewis, V. Experimental developments in movement disorders: update on proposed free radical mechanisms. Curr. Opin. Neurol 11, 335– 339 (1998). 10.1097/00019052-199808000-00009

[8]

Dawson, T.M. & Dawson, V.L. Nitric oxide synthase: role as a transmitter/mediator in the brain and endocrine system. Annu. Rev. Med. 47, 219–227 (1996). 10.1146/annurev.med.47.1.219

[9]

Bredt, D.S., Glatt, C.E., Huang, P.L., Fotuhi, M., Dawson, T.M. & Snyder, S.H. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7, 615–624 (1991). 10.1016/0896-6273(91)90374-9

[10]

Targeted disruption of the neuronal nitric oxide synthase gene

Paul L. Huang, Ted M. Dawson, David S. Bredt et al.

Cell 1993 10.1016/0092-8674(93)90615-w

[11]

Lowenstein, C.J., Glatt, C.S., Bredt, D.S. & Snyder, S.H. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA 89, 6711– 6715 (1992). 10.1073/pnas.89.15.6711

[12]

Keilhoff, G. et al. Patterns of nitric oxide synthase at the messenger RNA and protein levels during early rat brain development. Neuroscience 75, 1193–1201 (1996). 10.1016/0306-4522(96)00330-2

[13]

Simmons, M.L. & Murphy, S. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59, 897– 905 (1992). 10.1111/j.1471-4159.1992.tb08328.x

[14]

Wallace, M.N. & Fredens, K. Activated astrocytes of the mouse hippocampus contain high levels of NADPH-diaphorase. Neuroreport 3, 953–956 (1992). 10.1097/00001756-199211000-00001

[15]

Iadecola, C., Xu, X., Zhang, F., el-Fakahany, E.E. & Ross, M.E. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15, 52–59 (1995). 10.1038/jcbfm.1995.6

[16]

Hara, H. et al. Brain distribution of nitric oxide synthase in neuronal or endothelial nitric oxide synthase mutant mice using [3H]L-NG-nitro-arginine autoradiography. Neuroscience 75, 881–890 (1996). 10.1016/0306-4522(96)00313-2

[17]

Dinerman, J.L., Dawson, T.M., Schell, M.J., Snowman, A. & Snyder, S.H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl. Acad. Sci. USA 91, 4214– 4218 (1994). 10.1073/pnas.91.10.4214

[18]

Dawson, T.M. & Dawson, V.L. in Nitric oxide. Sources and Detection of NO; NO Synthase (ed. Packer, L.) 349–358 (Academic, New York, 1996). 10.1016/s0076-6879(96)68037-9

[19]

Schulz, J.B., Matthews, R.T., Muqit, M.M.K., Browne, S.E. & Beal, M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64, 936– 939 (1995). 10.1046/j.1471-4159.1995.64020936.x

[20]

Przedborski, S. et al. Role of neuronal nitric oxide in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93, 4565–4571 (1996). 10.1073/pnas.93.10.4565

[21]

Hantraye, P. et al. Inhibition of neuronal nitric oxide synthase prevents MPTP- induced parkinsonism in baboons. Nature Med. 2, 1017–1021 (1996). 10.1038/nm0996-1017

[22]

Matthews, R.T., Yang, L.C. & Beal, M.F. S-methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp. Neurol. 143, 282–286 (1997). 10.1006/exnr.1996.6406

[23]

Hunot, S. et al. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72, 355– 363 (1996). 10.1016/0306-4522(95)00578-1

[24]

Adamson, D.C. et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 1917–1921 (1996). 10.1126/science.274.5294.1917

[25]

Nathan, C. & Xie, Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269, 13725– 13728 (1994). 10.1016/s0021-9258(17)36703-0

[26]

Giovanni, A., Sieber, B.A., Heikkila, R.E. & Sonsalla, P.K. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. J. Pharmacol. Exp. Ther. 257, 691–697 (1991).

[27]

Forno, L.S., DeLanney, L.E., Irwin, I., Di Monte, D. & Langston, J.W. Astrocytes and Parkinson's disease. Prog. Brain Res. 94, 429– 436 (1992). 10.1016/s0079-6123(08)61770-7

[28]

Hirsch, E.C., Hunot, S., Damier, P. & Faucheux, B. Glial cells and inflammation in Parkinsons' disease: a role in neurodegeneration? Ann. Neurol. 44 (Suppl. 1), S115–S120 (1998). 10.1002/ana.410440717

[29]

Ridet, J.L., Malhotra, S.K., Privat, A. & Gage, F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20, 570–577 (1997). 10.1016/s0166-2236(97)01139-9

[30]

Gonzalez-Scarano, F. & Baltuch, G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219–240 (1999). 10.1146/annurev.neuro.22.1.219

[31]

Jackson-Lewis, V., Jakowec, M., Burke, R.E. & Przedborski, S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4, 257– 269 (1995). 10.1016/1055-8330(95)90015-2

[32]

Xia, Y. & Zweier, J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. USA 94, 6954–6958 (1997). 10.1073/pnas.94.13.6954

[33]

Murphy, S. et al. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16, 323–328 (1993). 10.1016/0166-2236(93)90109-y

[34]

Galea, E., Feinstein, D.L. & Reis, D.J. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA 89, 10945–10949 (1992). 10.1073/pnas.89.22.10945

[35]

Garcion, E. et al. Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25-dihydroxyvitamin D3. Glia 22, 282–294 (1998). 10.1002/(sici)1098-1136(199803)22:3<282::aid-glia7>3.0.co;2-7

[36]

Dugas, N. et al. Regulation by endogenous interleukin 10 of the expression of nitric oxide synthase induced after ligation of CD23 in human macrophages. Cytokine. 10, 680–689 (1998). 10.1006/cyto.1998.0352

[37]

Hunot, S. et al. FcεRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19, 3440– 3447 (1999). 10.1523/jneurosci.19-09-03440.1999

[38]

MacMicking, J., Xie, Q.-W. & Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323–350 (1997). 10.1146/annurev.immunol.15.1.323

[39]

Halliwell, B. & Gutteridge, J.M. in Free Radicals in Biology and Medicine (Clarendon, Oxford, 1991). 10.1016/0891-5849(91)90055-8

[40]

MacMicking, J. et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641–650 (1995). 10.1016/0092-8674(95)90085-3

[41]

Nathan, C. & Root, R.K. Hydrogen peroxide release from mouse peritoneal macrophages. Dependence on sequential activation and triggering. J. Exp. Med. 146, 1648– 1662 (1977). 10.1084/jem.146.6.1648

[42]

Leonard, C.S., Kerman, I., Blaha, G., Taveras, E. & Taylor, B. Interdigitation of nitric oxide synthase-, tyrosine hydroxylase- and serotonin-containing neurons in and around the laterodorsal and pedunculopontine tegmental nuclei of the guinea pig. J. Comp. Neurol. 362, 411–432 (1995). 10.1002/cne.903620309

[43]

Dawson, T.M. & Snyder, S.H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14, 5147–5159 (1994). 10.1523/jneurosci.14-09-05147.1994

[44]

Beckman, J.S. et al. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298, 438–445 (1992). 10.1016/0003-9861(92)90432-v

[45]

Ara, J. et al. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad. Sci. USA 95, 7659– 7663 (1998). 10.1073/pnas.95.13.7659

[46]

Almer, G., Vukosavic, S., Romero, N. & Przedborski, S. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 2415–2425 (1999). 10.1046/j.1471-4159.1999.0722415.x

[47]

Asmus, S.E. & Newman, S.W. Colocalization of tyrosine hydroxylase and Fos in the male Syrian hamster brain following different states of arousal. J. Neurobiol. 25, 156– 168 (1994). 10.1002/neu.480250207

[48]

Mandir, A.S. et al. Poly (ADP-ribose) polymerase activation mediates MPTP-induced parkinsonism. Proc. Natl. Acad. Sci. USA 96, 5774–5779 (1999). 10.1073/pnas.96.10.5774

[49]

Coggeshall, R.E. & Lekan, H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 364, 6– 15 (1996). 10.1002/(sici)1096-9861(19960101)364:1<6::aid-cne2>3.0.co;2-9

[50]

West, M.J. New stereological methods for counting neurons. Neurobiol. Aging 14, 275–285 (1993). 10.1016/0197-4580(93)90112-o

Showing 50 of 51 references

Cited By

876

Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson’s disease via the prosaposin-GPR37-IL-6 axis

Qiang Ma, Jin-Lan Tian · 2025

Cell Reports

Role of the iNOS isoform in the cardiovascular dysfunctions of male rats with 6-OHDA-induced Parkinsonism

Lorena de Jager, Camila Borecki Vidigal · 2023

Nitric Oxide

ACSL4 promotes microglia-mediated neuroinflammation by regulating lipid metabolism and VGLL4 expression

Xin Zhou, Rui Zhao · 2023

Brain, Behavior, and Immunity

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease

Arash Heidari, Niloufar Yazdanpanah · 2022

Journal of Neuroinflammation

The Role of Reactive Species on Innate Immunity

Celia Andrés, José Pérez de la Lastra · 2022

Vaccines

Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson’s Disease

Heeyoung An, Hyowon Lee · 2021

Experimental Neurobiology

Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation

Sandro Percário, Aline da Silva Barbosa · 2020

Oxidative Medicine and Cellular Lon...

Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease

Natasa Kustrimovic, Franca Marino · 2019

Current Medicinal Chemistry

Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease

Géraldine Gelders, Veerle Baekelandt · 2018

Journal of Immunology Research

GYY4137, an H2S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson’s Disease

Xiaoou Hou, Yuqing Yuan · 2017

Frontiers in Pharmacology

Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production

Victor Tapias, Xiaoping Hu · 2017

Experientia

Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System

Byung-Wook Kim, Kyoung Hoon Jeong · 2016

The Journal of Neuroscience

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Weidong Le · 2015

Molecular Neurobiology

CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration

Fabrine Sales Massafera Tristão, Márcio Lazzarini · 2015

Neurotoxicity Research

Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease

Hui-Ming Gao, Feng Zhang · 2011

Environmental Health Perspectives

T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Stanley H. Appel, David R. Beers · 2010

Trends in Immunology

Neuroinflammation in Parkinson’s Disease

Jae-Kyung Lee, Thi Tran · 2009

Journal of Neuroimmune Pharmacology

Glial Dysfunction in Parkin Null Mice: Effects of Aging

Rosa M. Solano, Maria J. Casarejos · 2008

The Journal of Neuroscience

Potential neuroprotective effect of low dose whole-body γ-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice

Yajie Liang, Shurong Li · 2006

Neuroscience Letters

Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity

Ji-Young Choi, Eun-Hee Jang · 2005

Free Radical Biology and Medicine

Metrics

876

Citations

51

References

Details

Published: Dec 01, 1999
Vol/Issue: 5(12)
Pages: 1403-1409
License: View

Authors

G

Gabriel T. Liberatore

V

Vernice Jackson-Lewis

W. Geoffrey McAuliffe

V

Valina L. Dawson

The Program in Cellular and Molecular Medicine,; Department of Neurology,; Department of Neuroscience,; Department of Physiology,

T

Ted M. Dawson

The Program in Cellular and Molecular Medicine,; Department of Neurology,; Department of Neuroscience,

S

Serge Przedborski

Cite This Article

Gabriel T. Liberatore, Vernice Jackson-Lewis, Slobodanka Vukosavic, et al. (1999). Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nature Medicine, 5(12), 1403-1409. https://doi.org/10.1038/70978

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

You May Also Like